Financial Statements

Biostar Pharmaceuticals, Inc. (BSPM)

$0.000001

0.00 (0.00%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2016 2015 2014 2013 2012
Retained Earnings (Previous Year) 3282423-
Net Income -6-2551-20
Stock Dividends ---0-043
Dividend Paid -----
Retained Earnings -33282423

PPE Schedule

Year 2016 2015 2014 2013 2012
Gross PPE 7887-
Annual Depreciation -1-2427
Capital Expenditure --0-3-1-0
Net PPE 67887

Intangible and Goodwill Schedule

Year 2016 2015 2014 2013 2012
Intangible and Goodwill (Previous Year) -----
New Purchases -----
Intangible and Goodwill -----

Biostar Pharmaceuticals, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Biostar Pharmaceuticals, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.